Home › Heart Valve Diseases › California › San Francisco
Heart Valve Diseases clinical trials in San Francisco, CA
4 studies for Heart Valve Diseases are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Recruiting
- Kaiser Permanente San Francisco Medical Center, San Francisco
VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Recruiting
- Sutter Health/ California Pacific Medical Center, San Francisco
- Kaiser Permanente San Francisco, San Francisco
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- Kaiser Permanente San Francisco Medical Center, San Francisco
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- University of California- San Francisco, San Francisco
About Heart Valve Diseases
Heart valve disease happens when one or more of your heart valves do not open or close correctly. This can affect your blood flow and strain your heart.
More about Heart Valve Diseases on MedlinePlus
Heart Valve Diseases trials in other cities
- Cleveland, OH10 studies
- New York City, NY10 studies
- Phoenix, AZ6 studies
- Cincinnati, OH6 studies
- Los Angeles, CA5 studies
- Philadelphia, PA5 studies
- Chicago, IL5 studies
- Wichita, KS5 studies
- Minneapolis, MN5 studies
- Pittsburgh, PA4 studies
- Boston, MA4 studies
- Atlanta, GA4 studies
Other studies in San Francisco
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Non-Small Cell Lung Cancer37 studies
- Heart Failure29 studies
- Metastatic Cancer25 studies
- Lung Cancer23 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Cardiovascular Disease20 studies
- Pancreatic Cancer19 studies
- Glioblastoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.